| Package | us.nlm.vsac |
| Type | ValueSet |
| Id | Id |
| FHIR Version | R4 |
| Source | http://fhir.org/packages/us.nlm.vsac/https://vsac.nlm.nih.gov/valueset/2.16.840.1.113762.1.4.1248.187/expansion |
| Url | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.187 |
| Version | 20230204 |
| Status | active |
| Date | 2023-02-04T01:02:55-05:00 |
| Name | RoutesOfAdministrationForOpioidAntagonists |
| Title | Routes of Administration for Opioid Antagonists |
| Experimental | False |
| Realm | us |
| Authority | hl7 |
| Purpose | (Clinical Focus: The purpose of this value set is to represent concepts for routes of administration for opioid antagonist administration to reverse opioid overdose which includes intranasal spray, inhalation, intramuscular, subcutaneous, or intravenous injection),(Data Element Scope: This value set may use a model element related to routes of medication administrations for opioid antagonists),(Inclusion Criteria: Includes concepts that represent intranasal, intramuscular, intravenous, subcutaneous, inhalation routes of administration for opioid antagonist administration),(Exclusion Criteria: Excludes enteral routes and other routes that are not intranasal, inhalation, intramuscular, intravenous or subcutaneous such as intradermal, intracoronary, intradiscal, intrapulmonary, etc.) |
No resources found
| CodeSystem | |
http://snomed.info/sct  | SNOMED CT (all versions) |
| http://snomed.info/sct | SNOMED CT |
| http://snomed.info/sct | veri |
FHIR{
"resourceType" : "ValueSet",
"id" : "2.16.840.1.113762.1.4.1248.187",
"meta" : {
"versionId" : "11",
"lastUpdated" : "2024-02-22T15:13:00.000-05:00",
"profile" : [
"http://hl7.org/fhir/StructureDefinition/shareablevalueset",
"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/computable-valueset-cqfm",
"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"
]
},
"extension" : [
{
"url" : "http://hl7.org/fhir/StructureDefinition/valueset-author",
"valueContactDetail" : {
"name" : "Mathematica PSI Author"
}
},
{
"url" : "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate",
"valueDate" : "2024-01-24"
},
{
"url" : "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate",
"valueDate" : "2023-02-04"
}
],
"url" : "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.187",
"identifier" : [
{
"system" : "urn:ietf:rfc:3986",
"value" : "urn:oid:2.16.840.1.113762.1.4.1248.187"
}
],
"version" : "20230204",
"name" : "RoutesOfAdministrationForOpioidAntagonists",
"title" : "Routes of Administration for Opioid Antagonists",
"status" : "active",
"date" : "2023-02-04T01:02:55-05:00",
"publisher" : "Mathematica PSI Steward",
"jurisdiction" : [
{
"coding" : [
{
"system" : "urn:iso:std:iso:3166",
"code" : "US"
}
]
}
],
"purpose" : "(Clinical Focus: The purpose of this value set is to represent concepts for routes of administration for opioid antagonist administration to reverse opioid overdose which includes intranasal spray, inhalation, intramuscular, subcutaneous, or intravenous injection),(Data Element Scope: This value set may use a model element related to routes of medication administrations for opioid antagonists),(Inclusion Criteria: Includes concepts that represent intranasal, intramuscular, intravenous, subcutaneous, inhalation routes of administration for opioid antagonist administration),(Exclusion Criteria: Excludes enteral routes and other routes that are not intranasal, inhalation, intramuscular, intravenous or subcutaneous such as intradermal, intracoronary, intradiscal, intrapulmonary, etc.)",
"compose" : {
"include" : [
{
"system" : "http://snomed.info/sct",
"concept" : [
{
"code" : "34206005",
"display" : "Subcutaneous route (qualifier value)"
},
{
"code" : "418114005",
"display" : "Intravenous central route (qualifier value)"
},
{
"code" : "419993007",
"display" : "Intravenous peripheral route (qualifier value)"
},
{
"code" : "447694001",
"display" : "Respiratory tract route (qualifier value)"
},
{
"code" : "46713006",
"display" : "Nasal route (qualifier value)"
},
{
"code" : "47625008",
"display" : "Intravenous route (qualifier value)"
},
{
"code" : "78421000",
"display" : "Intramuscular route (qualifier value)"
}
]
}
]
},
"expansion" : {
"identifier" : "urn:uuid:c16d6086-5bb7-4047-876d-40e1fc717c11",
"timestamp" : "2024-12-10T09:15:14-05:00",
"total" : 7,
"contains" : [
{
"system" : "http://snomed.info/sct",
"version" : "http://snomed.info/sct/731000124108/version/20240901",
"code" : "34206005",
"display" : "Subcutaneous route (qualifier value)"
},
{
"system" : "http://snomed.info/sct",
"version" : "http://snomed.info/sct/731000124108/version/20240901",
"code" : "418114005",
"display" : "Intravenous central route (qualifier value)"
},
{
"system" : "http://snomed.info/sct",
"version" : "http://snomed.info/sct/731000124108/version/20240901",
"code" : "419993007",
"display" : "Intravenous peripheral route (qualifier value)"
},
{
"system" : "http://snomed.info/sct",
"version" : "http://snomed.info/sct/731000124108/version/20240901",
"code" : "447694001",
"display" : "Respiratory tract route (qualifier value)"
},
{
"system" : "http://snomed.info/sct",
"version" : "http://snomed.info/sct/731000124108/version/20240901",
"code" : "46713006",
"display" : "Nasal route (qualifier value)"
},
{
"system" : "http://snomed.info/sct",
"version" : "http://snomed.info/sct/731000124108/version/20240901",
"code" : "47625008",
"display" : "Intravenous route (qualifier value)"
},
{
"system" : "http://snomed.info/sct",
"version" : "http://snomed.info/sct/731000124108/version/20240901",
"code" : "78421000",
"display" : "Intramuscular route (qualifier value)"
}
]
},
"text" : {
}
}
XIG built as of ??metadata-date??. Found ??metadata-resources?? resources in ??metadata-packages?? packages.